(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylami

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514234, 514236, 514255, 514267, 544117, 544250, A61K 3155, A61K 31505, C07D21308, C07D21314

Patent

active

046633200

ABSTRACT:
Compounds according to the formula ##STR1## an optical isomer thereof, or a pharmaceutically acceptable acid addition salt thereof wherein:

REFERENCES:
patent: 31617 (1884-06-01), Beverung, Jr. et al.
patent: 3932407 (1976-01-01), Beverung, Jr. et al.
patent: 4070470 (1978-01-01), Nakagawa et al.
patent: 4256748 (1981-03-01), Chodnekar et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 4596806 (1986-06-01), Ishikawa et al.
European Journal of Medicinal Chemistry, 1982-17, No. 6d, pp. 547-556, by Kienzle et al.
Journal of Pharmacology and Experimental Therapeutics, vol. 211, No. 1 (1979), pp. 26-30 by Hidaka et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylami does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylami, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylami will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2399452

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.